Analysis of Bacterial Metabolites in Breath Gas of Critically Ill Patients for Diagnosis of Ventilator-Associated Pneumonia—A Proof of Concept Study
Authors:
- Wojciech FilipiakWojciech Filipiak
- Robert WłodarskiRWRobert Włodarski
- Karolina ŻuchowskaKŻKarolina Żuchowska
- Alicja TracewskaATAlicja Tracewska
- Magdalena WiniarekMWMagdalena Winiarek
- Dawid DaszkiewiczDDDawid Daszkiewicz
- Marta MarszałekMMMarta Marszałek
- Dagmara DepkaDDDagmara Depka
- Tomasz BogielTBTomasz Bogiel
Open Access
- 21 November 2024
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 14 (12) , 1480
Abstract
Bacterial infection of the lower respiratory tract frequently occurs in mechanically ventilated patients and may develop into life-threatening conditions. Yet, existing diagnostic methods have moderate sensitivity and specificity, which results in the overuse of broad-spectrum antibiotics administered prophylactically. This study aims to evaluate the suitability of volatile bacterial metabolites for the breath-based test, which is used for diagnosing Ventilator-Associated Pneumonia (VAP). The in vitro experiments with pathogenic bacteria most prevalent in VAP etiology (i.e., Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa) were performed to identify bacteria-derived metabolites using a specially designed cultivation system enabling headspace sampling for GC-MS analysis. Thirty-nine compounds were found to be significantly metabolized by tested species and, therefore, selected for monitoring in the exhaled breath of critically ill, mechanically ventilated (MV) patients. The emission of volatiles from medical respiratory devices was investigated to estimate the risk of spoiling breath results with exogenous pollutants. Bacterial metabolites were then evaluated to differentiate VAP patients from non-infected MV controls using Receiver Operating Characteristic (ROC) analysis, with AUC, sensitivity, and specificity calculated. Nine bacterial metabolites that passed verification through a non-parametric ANOVA test for significance and LASSO penalization were identified as key discriminators between VAP and non-VAP patients. The diagnostic model achieved an AUC of 0.893, with sensitivity and specificity values of 87% and 82.4%, respectively, being competitive with traditional methods. Further validation could solidify its clinical utility in critical care settings.Keywords
All Related Versions
Funding Information
- Narodowym Centrum Nauki (2017/26/D/NZ6/00136)
This publication has 31 references indexed in Scilit:
- Diagnostic potential of breath analysis – Focus on the dynamics of volatile organic compoundsTrAC Trends in Analytical Chemistry, 2024
- Ventilator-associated pneumonia: pathobiological heterogeneity and diagnostic challengesNature Communications, 2024
- Progress and challenges of developing volatile metabolites from exhaled breath as a biomarker platformMetabolomics, 2024
- Modern approaches for detection of volatile organic compounds in metabolic studies focusing on pathogenic bacteria: Current state of the artJournal of Pharmaceutical Analysis, 2023
- Smelling the Disease: Diagnostic Potential of Breath AnalysisMolecular Diagnosis & Therapy, 2023
- The potential of volatile organic compounds-based breath analysis for COVID-19 screening: a systematic review & meta-analysis.Diagnostic Microbiology and Infectious Disease, 2021
- Exhaled breath compositions under varying respiratory rhythms reflects ventilatory variations: translating breathomics towards respiratory medicineScientific Reports, 2020
- Ventilator-associated pneumonia in adults: a narrative reviewIntensive Care Medicine, 2020
- Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitalsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2016
- Continuous Real Time Breath Gas Monitoring in the Clinical Environment by Proton-Transfer-Reaction-Time-of-Flight-Mass SpectrometryAnalytical Chemistry, 2013